The Children's Hospital of Philadelphia was awarded $38.9 million to advance gene‑editing therapies for hemophilia A and ...
Factor VIII (FVIII) replacement therapy is a cornerstone of treatment for many people with hemophilia A, a rare bleeding disorder caused by deficient or dysfunctional FVIII, a protein needed for blood ...
Recognition of hemophilia in women and girls is better, but challenges remain in getting accurate diagnoses and proper care, ...
Columnist Allyx Formalejo offers a meditation on the path toward finding balance in a relationship in the midst of difficult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results